A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis

Key facts

Sponsor

Yale University

Principal Investigator

Brittany Criaglow, MD

Yale University

Intervention

Observation(other)

Enrollment

21 enrolled

Eligibility

3 years · All sexes

Timeline

2015 – 2019

Study locations (1)

• Yale School of Medicine, New Haven, Connecticut, United States

Collaborators

Foundation for Ichthyosis & Related Skin Types (FIRST)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Congenital ichthyosiform erythroderma

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2, PHASE3NCT07538583
  Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
  Quoin Pharmaceuticals
• ENROLLING BY INVITATIONNCT03417856
  Defining the Skin and Blood Biomarkers of Ichthyosis
  Northwestern University

See all trials for Congenital ichthyosiform erythroderma →